This FDA Approval for Haegarda Just Changed Lives
https://pixabay.com/en/morning-sunrise-woman-silhouette-2243465/

This FDA Approval for Haegarda Just Changed Lives

A new therapy option for hereditary angioedema (HAE) has recently received FDA approval! Marketed as Haegarda by biopharmaceutical company, CSL Behring, this subcutaneous C1 Esterase Inhibitor is now usable in…

Continue Reading This FDA Approval for Haegarda Just Changed Lives
This Study Could Yield Urgently-Needed Data for the Prader-Willi Syndrome Community
Source: pixabay.com

This Study Could Yield Urgently-Needed Data for the Prader-Willi Syndrome Community

Soleno Therapeutics, Inc. of Capnia reported in early July of this year that the company plans to start a Phase 3 clinical trial for evaluating diazoxide choline controlled-release (DCCR) in…

Continue Reading This Study Could Yield Urgently-Needed Data for the Prader-Willi Syndrome Community
Doctors and Patient Advocates are Working Tirelessly for Waldenstrom Macroglobulinemia
Source: pixabay.com

Doctors and Patient Advocates are Working Tirelessly for Waldenstrom Macroglobulinemia

The latest in Waldenstrom macroglobulinemia news comes not only from the hospital clinic, but also from the race track, and the dance floor! As for the former, latest results are…

Continue Reading Doctors and Patient Advocates are Working Tirelessly for Waldenstrom Macroglobulinemia

Editor’s Choice: Treatments, Methods and Strategies in Coping with Rare Diseases

Happy August Patient Worthy Peeps! This week, we have some awesome posts to keep you up-to-date on some of the latest rare disease developments. There's news on a hopeful possible…

Continue Reading Editor’s Choice: Treatments, Methods and Strategies in Coping with Rare Diseases